Influential Medicine Providing Access to Clinical Trials (IMPACT)

Organization
Leukemia & Lymphoma Society (LLS)
Type
Foundation
LOI Due Date
01-06-2023
Application Due Date
03-10-2023
Brief Description

LLS seeks to bring clinical trials to the patients through the Influential Medicine Providing Access to Clinical Trials (IMPACT) program.

The overall goal is to expand clinical trial access to patients by having clinical trial participation occur mainly at local community oncology centers. These clinical trials will be hosted by the major cancer center (IMPACT hub) who will partner with community-based oncologists to facilitate recruitment and participation of patients at community oncology centers. The trials should be high-quality, interventional, and can target any hematological malignancy as well as any relevant premalignant condition.

Each IMPACT award will be comprised of a hub that will establish a network of partnerships with community-based oncology centers. The hub is based at a major academic cancer research and treatment center (the host institution) which will oversee the clinical trials. The hub will coordinate with their community oncology partners to recruit patients on the trials as well as to oversee the proper conduct of trial activity occurring at the community centers.

Award information:

  • The maximal award value is $250,000 for each year of the five-year grant, which may include overhead costs of up to 5%.
  • An additional $150,000 may be provided to strong IMPACT programs with well-justified expenses.
  • The funding is meant to support infrastructure to implement trials at the community locations. All trial costs must be supported by other sources.
  • LLS IMPACT funding is for 5 years. It is expected that IMPACT awardees will work towards a goal of sustainability of the program beyond LLS funding.